New Oral Anticoagulants for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients: A Randomized Placebo-Controlled, Double-Blind Clinical Trial
New Oral Anticoagulants for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients: A Randomized Placebo-Controlled, Double-Blind Clinical Trial
用于预防高危动态癌症患者静脉血栓栓塞的新型口服抗凝剂：一项随机安慰剂对照、双盲临床试验
批准号：
252838
负责人：
Wells Philip S
金额：
$60.96万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-03-01 至 2015-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer may cause the blood to clot easier, and as a result, new clots in the veins of arms, legs and lungs are very frequent in patients with cancer. The consequences of these new clots are related to reduced quality of life, delay in treatment against ca
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and Validation of Clinical Prediction Rules for Bleeding for Patients on Anticoagulation Therapy for Venous Thromboembolism
-
批准号：279357
-
项目类别：Operating Grants
-
资助金额：$36.5万
-
财政年份：2013
-
负责人：Wells Philip S
-
依托单位：
海外基金
